You have a lot to protect, bank more than cord blood.

Possibilities for the Future: New Opportunities for Stem Cells

Someday, having more cells available through Placental and Cord Blood Banking may prove beneficial for new medical treatments in an emerging medical field called regenerative medicine.

This groundbreaking medical approach involves repairing or replacing damaged tissues and organs and restoring their critical functions.*,1,2

Studies now show that stem cells referred to as mesenchymal cells † may prove useful for regenerative treatments.3-6 Indeed, in laboratories, scientists have learned that mesenchymal stem cells have strong potential to repair bones and regrow cartilage.6 Placental and cord blood contain mesenchymal-like cells, including CD105+200+ cells.6,7 With Placental and Cord Blood Banking, you can ensure that more of these cells are available so that your family can take full advantage of new treatments that may emerge.

More CD34+ cells. More mesenchymal-like cells. More cells overall.

When it comes to lifesaving potential, only LifebankUSA gives you MORE.

"This field [regenerative medicine] holds the promise of regenerating damaged tissues and organs in the body by stimulating previously irreparable organs to heal themselves. Regenerative medicine also empowers scientists to grow tissues and organs in the laboratory and safely implant them when the body cannot heal itself."
-National Institutes of Health
http://stemcells.nih.gov/info/scireport/chapter8.asp

* These uses are not consistent with current labeling, are investigational and may never become standard therapy.
† Mesenchymal is pronounced muh-ZINK-i-mul.
Data on file, LifebankUSA; 2010.
Cord blood and placenta-derived stem cells banked with LifebankUSA are indicated for hematopoietic reconstitution (the reformation of blood cellular components) for autologous use or use in first or second degree blood relatives. Any use of cord blood and placental stem cells other than for hematopoietic reconstitution is considered investigational, including regenerative medicine* therapies.

The chance that a child will use his/her own stored stem cells during his/her lifetime for currently treated conditions is estimated at 1 in 400.† These odds may increase if there is a family history of certain blood disorders or cancers. The potential risks and benefits of stem cell transplantation vary and depend on many factors, such as the amount and quality of the stem cells collected, the HLA compatibility between recipient and donor, and the client's overall health. Talk with your health care provider. For more information, call us at 1-877-LIFEBANKUSA ( 1-877-543-3226 ).

*These uses are not consistent with current labeling, are investigational and may never become standard therapy.
† Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. Biol Blood Marrow Transplant. 2008;14(3):316-322.

References:
  1. Mason C, Dunnill P. A brief definition of regenerative medicine. Regen Med. 2008;3(1):1-5.
  2. US Department of Health and Human Services. 2020: a new vision-a future for regenerative medicine. http://www.hhs.gov/reference/newfuture.shtml. Accessed Nov 14, 2011.
  3. Harris DT. Non-haematological uses of cord blood stem cells. Br J Haematol. 2009;147(2):177-184.
  4. Richardson SM, Hoyland JA, Mobasheri R, Csaki C, Shakibaei M, Mobasheri A. Mesenchymal stem cells in regenerative medicine: opportunities and challenges for articular cartilage and intervertebral disc tissue engineering. J Cell Physiol. 2010;222(1):23-32.
  5. Yen BL, Huang H-I, Chien C-C, et al. Isolation of multipotent cells from human term placenta. Stem Cells. 2005;23(1):3-9.
  6. da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells. 2008;26(9):2287-2299.
  7. Data on file, LifebankUSA; 2010.